Related references
Note: Only part of the references are listed.Characterization of gene-activated human acid-beta-glucosidase: Crystal structure, glycan composition, and internalization into macrophages
Boris Brumshtein et al.
GLYCOBIOLOGY (2010)
Mutations for Gaucher Disease Confer High Susceptibility to Parkinson Disease
Jun Mitsui et al.
ARCHIVES OF NEUROLOGY (2009)
Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability
Raquel L. Lieberman et al.
BIOCHEMISTRY (2009)
Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison with N-(n-nonyl)-Deoxynojirimycin
Zhuo Luan et al.
CHEMBIOCHEM (2009)
Rational Design and Synthesis of Highly Potent Pharmacological Chaperones for Treatment of N370S Mutant Gaucher Disease
Guan-Nan Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Participation of asparagine 370 and glutamine 235 in the catalysis by acid β-glucosidase: The enzyme deficient in Gaucher disease
Benjamin Liou et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Predicting free energy changes using structural ensembles
Alexander Benedix et al.
NATURE METHODS (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Human Gene Mutation Database: 2008 update
Peter D. Stenson et al.
GENOME MEDICINE (2009)
Acid β-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy
Yaacov Kacher et al.
BIOLOGICAL CHEMISTRY (2008)
Isofagomine Induced Stabilization of Glucocerebrosidase
Gregory J. Kornhaber et al.
CHEMBIOCHEM (2008)
An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions -: Relevance for Gaucher disease
Silvia Atrian et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid β-glucosidase -: Insights into the mechanism of chemical chaperone action in Gaucher disease
Boris Brumshtein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Three classes of gluclocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease
Wei Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-β-glucosidase
Richard Steet et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease
Raquel L. Lieberman et al.
NATURE CHEMICAL BIOLOGY (2007)
Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention
Zhanqian Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy
Michael Beck
HUMAN GENETICS (2007)
Structural comparison of differently glycosylated forms of acid-β-glucosidase, the defective enzyme in Gaucher disease
Boris Brumshtein et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms
Richard A. Steet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients
Hui-Hwa Chang et al.
FEBS JOURNAL (2006)
Developing a move-set for protein model refinement
Marc N. Offman et al.
BIOINFORMATICS (2006)
Therapeutic strategies to ameliorate lysosomal storage disorders - a focus on Gaucher disease
A. R. Sawkar et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Analyses of variant acid β-glucosidases -: Effects of Gaucher disease mutations
B Liou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Increased incidence of cancer in adult Gaucher disease in Western Europe
M de Fost et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
The N370S (Asn370→ Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C
R Salvioli et al.
BIOCHEMICAL JOURNAL (2005)
H++:: a server for estimating pKas and adding missing hydrogens to macromolecules
JC Gordon et al.
NUCLEIC ACIDS RESEARCH (2005)
X-ray structure of human acid-β-glucosidase covalently bound to conduritol-B-epoxide -: Implications for Gaucher disease.
L Premkumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Gaucher disease and cancer incidence: a study from the Gaucher Registry
BE Rosenbloom et al.
BLOOD (2005)
Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic
A Zimran et al.
BLOOD CELLS MOLECULES AND DISEASES (2005)
Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations
P Alfonso et al.
BLOOD CELLS MOLECULES AND DISEASES (2005)
N-octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells:: a potential chemical chaperone therapy for Gaucher disease
H Lin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Constant pH molecular dynamics in generalized born implicit solvent
J Mongan et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Expression and functional characterization of mutated glucocerebrosidase alleles causing Gaucher disease in Spanish patients
P Alfonso et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Enzyme replacement in Gaucher disease
E Beutler
PLOS MEDICINE (2004)
The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data
CT Porter et al.
NUCLEIC ACIDS RESEARCH (2004)
Functional analysis of 13 GBA mutant Alleles identified in Gaucher disease patients:: Pathogenic changes and modifier polymorphisms
M Montfort et al.
HUMAN MUTATION (2004)
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations
Y Duan et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
A graph-theory algorithm for rapid protein side-chain prediction
AA Canutescu et al.
PROTEIN SCIENCE (2003)
A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity
JQ Fan
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
X-ray structure of human acid-β-glucosidase, the defective enzyme in Gaucher disease
H Dvir et al.
EMBO REPORTS (2003)
POPS: a fast algorithm for solvent accessible surface areas at atomic and residue level
L Cavallo et al.
NUCLEIC ACIDS RESEARCH (2003)
Transient expression of wild-type and mutant glucocerebrosidases in hybrid vaccinia expression system
K Hodanová et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2003)
Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1
GM Pastores et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2003)
Chemical chaperones increase the cellular activity of N370S β-glucosidase:: A therapeutic strategy for Gaucher disease
AR Sawkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: A report from the Gaucher Registry
NJ Weinreb et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Share Paper
